Top

Published in:

17-05-2022 | COVID-19 | Correspondence

The need to define “who” rather than “if” for ECMO in COVID-19

Authors: Stephen Whebell, Joe Zhang, Rebecca Lewis, Michael Berry, Stephane Ledot, Andrew Retter, Luigi Camporota

Published in: Intensive Care Medicine | Issue 7/2022

Excerpt

We thank Watanabe [1] and Wendel-Garcia et al. [2] for the interest they have taken in our article [3]. Both raise valid points regarding the characteristics of patients selected for matching, the potential for unmeasured confounding, and the method of extracorporeal membrane oxygenation (ECMO) delivery. …

Watanabe A (2022) Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: “perceived futility” and potential underestimation of ECMO’s effect. Intensive Care Med. https://doi.org/10.1007/s00134-022-06711-3CrossRefPubMedPubMedCentral

Wendel-Garcia PD, Seeliger B, Stahl K et al (2022) Where is the imperceptible difference? Intensive Care Med. https://doi.org/10.1007/s00134-022-06710-4CrossRefPubMedPubMedCentral

Whebell S, Zhang J, Lewis R et al (2022) Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study. Intensive Care Med 48:467–478. https://doi.org/10.1007/s00134-022-06645-wCrossRefPubMedPubMedCentral

Whebell S, Zhang J, Lewis R et al (2022) Correction to: Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study. Intensive Care Med. https://doi.org/10.1007/s00134-022-06681-6CrossRefPubMedPubMedCentral

Title: The need to define “who” rather than “if” for ECMO in COVID-19
Authors: Stephen Whebell
Joe Zhang
Rebecca Lewis
Michael Berry
Stephane Ledot
Andrew Retter
Luigi Camporota
Publication date: 17-05-2022
Publisher: Springer Berlin Heidelberg
Keywords: COVID-19
COVID-19
ECMO
ECMO
Published in: Intensive Care Medicine / Issue 7/2022
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-022-06732-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The need to define “who” rather than “if” for ECMO in COVID-19

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2022

Death during life sustaining treatment must be considered a failure but can be acceptable if the treatment was proportional

Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial

Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

Multistakeholder social media peer review and fixing slips

Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial

Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial